마이크로어레이 스캐너 시장 : 제품 유형, 용도 및 최종 용도별 - 세계 예측(2024-2032년)

Microarray scanners market size will record 8.2% CAGR between 2024 and 2032 driven by the expanding applications of microarray technology in genomic research, personalized medicine, and diagnostics. Microarray scanners are essential for analyzing gene expression, genetic variations, and biomarkers across various research fields, including cancer research, drug discovery, and genetic disorder studies.

With researchers and clinicians seeking more detailed insights into genetic data to tailor treatments and develop new therapeutic approaches, the demand for advanced microarray scanners capable of delivering accurate and comprehensive results is on the rise. For instance, in August 2023, Thermo Fisher Scientific launched a new chromosomal microarray for increasing productivity, efficacy, and profitability in cytogenetic research labs.

Improvements, such as higher resolution imaging, increased scanning speed, and more sophisticated data analysis tools are also making microarray scanners more efficient and user-friendly. The integration of automation and software solutions into these scanners for reducing manual intervention and increasing throughput will also drive the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the market size from the charge-coupled devices microarray scanners segment will gain notable traction during 2024-2032 due to their high sensitivity and superior image quality. Charge-coupled device (CCD) technology enables precise detection of fluorescent signals with excellent resolution, which is crucial for accurately analyzing the intricate details of microarray data. The ability of CCD-based scanners to capture high-resolution images at a rapid pace is also enhancing throughput and efficiency, making them particularly valuable for large-scale genomic studies.

In terms of application, the microarray scanners industry from the drug discovery segment will witness significant growth up to 2032 driven by rapid adoption of technologies in high-throughput screening and analysis of drug candidates. Microarray scanners enable researchers to simultaneously evaluate thousands of genetic and protein targets for facilitating the identification of potential drug compounds and their effects on various biological pathways.

Asia Pacific microarray scanners market is expected to generate notable revenue during 2024-2032 attributed to the strong research infrastructure and increasing investments in genomics and personalized medicine. The rising prevalence of chronic diseases and the growing emphasis on tailored healthcare solutions are further propelling the demand for high-throughput technologies, adding to the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Advancements in genomics and proteomics research
    • 3.2.1.2 Rising prevalence of chronic diseases
    • 3.2.1.3 Growing technological advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with microarray scanners
    • 3.2.2.2 Stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Fluorescence microarray scanners
• 5.3 Charge-coupled devices microarray scanners
• 5.4 Colorimetric microarray scanners
• 5.5 Other types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Gene expression analysis
• 6.3 Protein microarrays
• 6.4 Drug discovery
• 6.5 Genotyping and SNP analysis
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Diagnostic laboratories
• 7.5 Academic and research institutes
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agilent Technologies, Inc.
• 9.2 Arrayit Corporation
• 9.3 Aushon BioSystems
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Danaher Corporation
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Hitachi High-Tech Corporation
• 9.8 Illumina, Inc.
• 9.9 LI-COR Biosciences
• 9.10 Microarrays, Inc.
• 9.11 Oxford Gene Technology
• 9.12 PerkinElmer, Inc.
• 9.13 SciGene Corporation
• 9.14 Tecan Group Ltd.
• 9.15 Thermo Fisher Scientific, Inc.